chr9-35683243-T-TG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003289.4(TPM2):c.773-3dupC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.314 in 1,484,044 control chromosomes in the GnomAD database, including 61,278 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6387 hom., cov: 0)
Exomes 𝑓: 0.32 ( 54891 hom. )
Consequence
TPM2
NM_003289.4 splice_region, intron
NM_003289.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.23
Genes affected
TPM2 (HGNC:12011): (tropomyosin 2) This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-35683243-T-TG is Benign according to our data. Variant chr9-35683243-T-TG is described in ClinVar as [Likely_benign]. Clinvar id is 94124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.355 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM2 | NM_003289.4 | c.773-3dupC | splice_region_variant, intron_variant | ENST00000645482.3 | NP_003280.2 | |||
TPM2 | NM_001301226.2 | c.772+1002dupC | intron_variant | NP_001288155.1 | ||||
TPM2 | NM_001301227.2 | c.773-3dupC | splice_region_variant, intron_variant | NP_001288156.1 | ||||
TPM2 | NM_213674.1 | c.772+1002dupC | intron_variant | NP_998839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM2 | ENST00000645482.3 | c.773-3dupC | splice_region_variant, intron_variant | NM_003289.4 | ENSP00000496494.2 |
Frequencies
GnomAD3 genomes AF: 0.267 AC: 40146AN: 150290Hom.: 6392 Cov.: 0
GnomAD3 genomes
AF:
AC:
40146
AN:
150290
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.300 AC: 46173AN: 154034Hom.: 5997 AF XY: 0.301 AC XY: 24387AN XY: 81146
GnomAD3 exomes
AF:
AC:
46173
AN:
154034
Hom.:
AF XY:
AC XY:
24387
AN XY:
81146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.320 AC: 426562AN: 1333638Hom.: 54891 Cov.: 34 AF XY: 0.319 AC XY: 210613AN XY: 659816
GnomAD4 exome
AF:
AC:
426562
AN:
1333638
Hom.:
Cov.:
34
AF XY:
AC XY:
210613
AN XY:
659816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.267 AC: 40138AN: 150406Hom.: 6387 Cov.: 0 AF XY: 0.264 AC XY: 19388AN XY: 73458
GnomAD4 genome
AF:
AC:
40138
AN:
150406
Hom.:
Cov.:
0
AF XY:
AC XY:
19388
AN XY:
73458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Jan 16, 2013 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:2Other:1
not provided, no classification provided | literature only | TPM2 homepage - Leiden Muscular Dystrophy pages | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 12, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Arthrogryposis, distal, type 1A Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Nemaline Myopathy, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Arthrogryposis multiplex congenita Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at